HIGHLIGHTS
- who: - benralizumab - reslizumab et al. from the (UNIVERSITY) have published the paper: Allergologie select, Volume 4/2020 ( 53 - 68 ) Correspondence to Prof. Dr. Ludger Klimek Zentrum für Rhinologie und Allergologie An den Quellen 10 65183 Wiesbaden ludger.klimek, in the Journal: (JOURNAL) of February/11,/2020
- what: The currently available data suggest that the risk of developing a severe course of COVID-19 is probably not increased in patients with allergies and atopy-associated diseases.
SUMMARY
Prolongation of the injection interval can be considered (as indicated in the summary of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.